Organization | University of Ouagadougou

University of Ouagadougou Report issue

Academic/Hospital Phase 3 Phase 4

Founded: Ouagadougou Burkina Faso (1974)

Organization Overview

First Clinical Trial

2004

NCT00730366

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

University of Ouagadougou, Burkina Faso

Active Ingredients

Drugs in Phase 4 Trials (2)

pyrimethamine (daraprim) (2 trials)

sulfadoxine (2 trials)

Drugs in Phase 3 Trials (7)

abacavir (ziagen) (1 trial)

chloroquine (1 trial)

efavirenz (sustiva) (1 trial)

lamivudine (epivir) (2 trials)

lopinavir (Kaletra) (2 trials)

ritonavir (Norvir) (2 trials)

zidovudine (retrovir) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

HIV Infections (Phase 3)

Malaria (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 9